Skip to content
Recall Observatory FDA recall evidence

Drug product

Carbamazepine Tablets USP, 200 mg, 1000 Tablets per Bottle, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 26110 Distributed by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4005-3.

D-0049-2015

October 21, 2014

Class III

Product summary

Firm
Taro Pharmaceuticals U.S.A., Inc.
Event
Event 69413
Status
Terminated
Classification
Class III
Quantity
1,966 bottles
Official record key
drug-enforcement:D-0049-2015

Official wording

Reason: Marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system. An alternate manufacturing site for the Carbamazepine API final intermediate was pending approval.

Code information: Lot 137393, exp. 10/2016

Distribution pattern: IL, OH, LA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system. An alternate manufacturing site for the Carbamazepine API final intermediate was pending approval.